Foresight Global Investors, Inc. Novartis Ag Transaction History
Foresight Global Investors, Inc.
- $168 Billion
- Q3 2025
A detailed history of Foresight Global Investors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Foresight Global Investors, Inc. holds 171,683 shares of NVS stock, worth $22.6 Million. This represents 13.07% of its overall portfolio holdings.
Number of Shares
171,683
Previous 164,924
4.1%
Holding current value
$22.6 Million
Previous $20 Billion
10.32%
% of portfolio
13.07%
Previous 14.17%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...